 |
BU ADC Job Openings
The BU ADC has openings for two Clinical Research Assistants. One research assistant will be investigating new methods of determining driving safety in the elderly. The second position requires coordinating a study looking at the relationship between mild thyroid dysfunction and cognitive impairment. Please click here for more in-depth descriptions.
|
Participate in the New Vaccine Study for Alzheimer's disease
The BU ADC is currently enrolling participants for the launch of a new treatment study for individuals with Alzheimer's disease (AD). The Investigational Clinical Amyloid Research in Alzheimer's (ICARA) study is investigating the use of a vaccine drug called Bapineuzumab to slow the progression of AD. For more information, click here.
|
Genetic Testing for Alzheimer's disease in the News
ADC Clinical Core Director, Dr. Robert C. Green, recently appeared on a broadcast of the CBS Evening News where he discussed new commercial methods of genetic testing for Alzheimer's disease. Read the article online or watch the video of the broadcast by clicking here.
|
Flurizan Study in the News
The BU ADC is a site for the Flurizan study. Learn more. Also, read the recent USA Today story on the study and view the local ABC news clip that recently featured Flurizan. Click here to see the Flurizan Scientific Advisory Board. Stay tuned for study results, which will be presented at the 2008 International Conference on Alzheimer's Disease in July! |
Home-Based Assessment Study
We are now enrolling participants in a study
that seeks to determine how easy it is to detect cognitive changes in adults aged 75 years or older from the comfort of their homes. Three at-home methods are used to detect cognitive change, including paper questionnaires, telephone interviews, and computer-based assessments. Learn more. |
"At the Crossroads" event in the news
Dr. Robert Stern and colleagues recently presented findings on driving and dementia at the "At the Crossroads: Caregiving, Dementia, and the Driving Decision" conference at the MIT Faculty Club. Read about the event at the following links:
Boston Globe article
The Patriot Ledger article and webcast |
Alzheimer's Disease Webcast Seminar
ADC Faculty member Dr. Anil Nair was an expert guest on a special healthtalk.com online seminar titled, "Top Five Dementia Myths Debunked." Listen to the replay here.
|
|
|
|
 |
October 15
BU ADC Seminar Series
Speaker: Dr. Roberta Clarke, Associate Professor of Marketing in the Health Sector Management Program at Boston University
Title: "How marketing went wrong in the pharmaceutical industry? Implications for old and new drugs"
McNary R-115 12:10 pm. Seating is limited |
October 30
BU ADC & Alzheimer's Association MA/NH Chapters
Speaker: Dale B. Schenk, Ph.D. Executive Vice President & Chief Scientific Officer Elan Pharmaceuticals
Chairman, Alzheimer's Association Research Rountable
Title: "Aβ Immunology: A Pathology Modifying Approach to Alzheimer's disease"
McNary L-112 12:00 pm. Seating is limited |
November 5
BU ADC Seminar Series
Speaker: Dr. Ci-Di Chen. Research Assistant Professor Boston University School of Medicine.
Title: TBD
McNary R-115 12:10 pm. Seating is limited
|
November 12
BU ADC Seminar Series
Speaker: Sudha Seshadri M.D. Associate Professor of Neurology and Co-Director of Medical Education for the Neurology Residency and Clerkship programs Boston University School of Medicine.
Title: TBD
McNary R-115 12:10 pm. Seating is limited |
November 19
BU ADC Seminar Series
Speaker: Holly Westervelt Ph.D. Clinical Assistant Professor, Warren Alpert Medical School of Brown University
Title: "Olfaction in Alzheimer's Disease and Other Neurodegenerative Disorders"
McNary R-115 12:10 pm. Seating is limited |
December 3
BU ADC Seminar Series
Speaker: Martin Sadowski M.D., Ph.D. Assistant Professor of Neurology, Psychiatry, and Pharmacology
New York University School of Medicine
Title: "Apolipoprotein E and Alzheimer’s disease Well-established risk factor and an emerging therapeutic target"
McNary R-115 12:10 pm. Seating is limited |
December 10
BU ADC Seminar Series
Speaker: Ann Messner, Ph.D.
Title: "Engineered Antibodies Against Neurodegenerative Diseases"
McNary R-115 12:10 pm. Seating is limited
|
February 15
Pilot Grant Program Proposal Deadline
The BU ADC is now accepting new proposals for the Pilot Grant Program. At least two selected grants will be funded in the amount of $25,000 for one year. The deadline for proposal submission is February 15, 2009. For more information, click here. |
| |
|
|
